Grail San Francisco
GRAIL is a healthcare company dedicated to early cancer detection through innovative technologies like the Galleri® multi-cancer early detection test. Their mission is to detect cancer early, when it can be cured, and to transform cancer screening and care by harnessing genomics and machine learning. They collaborate with leading health systems and academic centers worldwide to bring their groundbreaking technology to patients.
Industries
Nr. of Employees
medium (51-250)
Products
Multi-cancer early detection blood test (MCED)
A blood-based screening assay that sequences circulating cell-free DNA and applies methylation-targeted analysis and machine learning to detect cancer signals and predict likely tissue-of-origin for positive results; intended to complement recommended single-cancer screening.
Diagnostic aid blood test for symptomatic patients (DAC)
A blood-based diagnostic aid intended to accelerate diagnostic resolution in patients presenting with non-specific signs and symptoms and a clinical suspicion of cancer by detecting cancer-associated methylation signals and suggesting likely cancer location.
Multi-cancer early detection blood test (MCED)
A blood-based screening assay that sequences circulating cell-free DNA and applies methylation-targeted analysis and machine learning to detect cancer signals and predict likely tissue-of-origin for positive results; intended to complement recommended single-cancer screening.
Diagnostic aid blood test for symptomatic patients (DAC)
A blood-based diagnostic aid intended to accelerate diagnostic resolution in patients presenting with non-specific signs and symptoms and a clinical suspicion of cancer by detecting cancer-associated methylation signals and suggesting likely cancer location.
Services
External Sponsored Research Program (ISTs and collaborations)
Competitive funding and collaboration program supporting investigator-sponsored trials and research collaborations, including LOI intake, protocol and budget review, contracting, and study start-up packages.
Biopharma research-use-only assay access and partnerships
Provision of post-diagnosis, research-use-only blood-based liquid biopsy assays and collaborative programs for biopharma clinical research applications.
Provider ordering and workflow integration
Services to streamline test ordering and result delivery by integrating test ordering into provider workflows and health IT platforms.
External Sponsored Research Program (ISTs and collaborations)
Competitive funding and collaboration program supporting investigator-sponsored trials and research collaborations, including LOI intake, protocol and budget review, contracting, and study start-up packages.
Biopharma research-use-only assay access and partnerships
Provision of post-diagnosis, research-use-only blood-based liquid biopsy assays and collaborative programs for biopharma clinical research applications.
Provider ordering and workflow integration
Services to streamline test ordering and result delivery by integrating test ordering into provider workflows and health IT platforms.
Expertise Areas
- Multi-cancer early detection (MCED)
- Cell-free DNA (cfDNA) analysis
- Targeted methylation assay development
- Machine learning for diagnostic classifiers
Key Technologies
- Targeted methylation sequencing
- Cell-free DNA (cfDNA) sequencing
- Next-generation sequencing
- Machine learning classifiers